These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2827182)

  • 21. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro induced and expanded Epstein Barr virus-specific cytotoxic T lymphocytes can specifically kill nasopharyngeal carcinoma cells].
    Chen LP; Huang JQ; Zhou TC; Zhang SX; Wang JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1431-3. PubMed ID: 18753079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
    Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus.
    Turkay S; Odemis E; Karadag A
    J Natl Med Assoc; 2006 Aug; 98(8):1350-2. PubMed ID: 16916136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kawasaki disease and Epstein-Barr virus.
    Kikuta H; Matsumoto S; Osato T
    Acta Paediatr Jpn; 1991 Dec; 33(6):765-70. PubMed ID: 1666245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kawasaki disease and Epstein-Barr virus infection.
    Osato T; Kikuta H; Okano M; Mizuno F; Konno M; Ishikawa N; Hirai K; Matsumoto S
    Prog Clin Biol Res; 1987; 250():113-6. PubMed ID: 2827177
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kawasaki disease associated with Epstein-Barr virus].
    Harnoi C; Benderly A; Etzioni A
    Harefuah; 1989 Oct; 117(7-8):194-5. PubMed ID: 2555288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kawasaki-like disease in a young adult. Association with primary Epstein-Barr virus infection.
    Barbour AG; Krueger GG; Feorino PM; Smith CB
    JAMA; 1979 Jan; 241(4):397-8. PubMed ID: 214590
    [No Abstract]   [Full Text] [Related]  

  • 29. Kawasaki disease without Epstein-Barr virus.
    Trust S; Groudine S
    JAMA; 1979 Sep; 242(12):1260. PubMed ID: 225579
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection.
    Okano M; Hase N; Sakiyama Y; Matsumoto S
    Pediatr Infect Dis J; 1990 Feb; 9(2):139-41. PubMed ID: 2156214
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrence of Kawasaki disease and Epstein-Barr virus infection.
    Kikuta H; Matsumoto S; Yanase Y; Kawasaki T; Mizuno F; Osato T
    J Infect Dis; 1990 Nov; 162(5):1215. PubMed ID: 2172398
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms.
    Kikuta H; Sakiyama Y; Matsumoto S; Hamada I; Yazaki M; Iwaki T; Nakano M
    J Pediatr; 1993 Jul; 123(1):90-2. PubMed ID: 8391571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thoughts on Kawasaki disease etiology.
    Morens DM
    JAMA; 1979 Jan; 241(4):399. PubMed ID: 214591
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. VII. A weak response to Epstein-Barr viral capsid antigen in mice infected neonatally with S. pyogenes.
    Akiyama T; Osawa N; Yamaura N; Yashiro K; Watanabe M
    Acta Paediatr Jpn; 1988 Dec; 30(6):654-61. PubMed ID: 2853553
    [No Abstract]   [Full Text] [Related]  

  • 35. [Factors in the development of Kawasaki disease and specificity of immunity in children].
    Matsuoka Y; Yata J
    Nihon Rinsho; 1983 Sep; 41(9):2047-51. PubMed ID: 6363750
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible polyclonal B cell activation in mucocutaneous lymph node syndrome.
    Furukawa F; Ohshio G; Hamashima Y
    Eur J Pediatr; 1986 Apr; 145(1-2):104-8. PubMed ID: 3015624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kawasaki disease and Epstein-Barr virus.
    Iwanaga M; Takada K; Osato T; Saeki Y; Noro S; Sakurada N
    Lancet; 1981 Apr; 1(8226):938-9. PubMed ID: 6112339
    [No Abstract]   [Full Text] [Related]  

  • 38. Aetiology of Kawasaki disease.
    Bannister BA; Edwards S; Ibata G
    Arch Dis Child; 1989 Mar; 64(3):397-8. PubMed ID: 2539788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superantigens and Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
    [No Abstract]   [Full Text] [Related]  

  • 40. Kawasaki disease and an unusual primary infection with Epstein-Barr virus.
    Kikuta H; Mizuno F; Osato T; Konno M; Ishikawa N; Noro S; Sakurada N
    Pediatrics; 1984 Mar; 73(3):413-4. PubMed ID: 6322099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.